CNNM3 Polyclonal Antibody: A Key Tool in Ion Transport and Cancer Research

/ General / By

The CNNM3 Polyclonal Antibody is an essential reagent for studying CNNM3 (Cyclin M3), a magnesium transporter involved in cellular ion homeostasis. CNNM3 plays a crucial role in regulating magnesium levels, cell proliferation, and metabolism, and is implicated in various cancers, making it a valuable target in biomedical research.

Overview of CNNM3

Key Features of CNNM3:

  • Full Name: Cyclin M3 (CNNM3).
  • Function:
    • Magnesium ion transport.
    • Regulation of intracellular magnesium homeostasis.
    • Cell proliferation and metabolic pathways.
  • Clinical Significance:
    • CNNM3 dysregulation is associated with tumor progression and metastasis in cancers such as colorectal and breast cancer.
  • Localization:
    • Predominantly in the plasma membrane but also observed in intracellular compartments.

Features of the CNNM3 Polyclonal Antibody

  1. High Specificity:
    • Specifically targets endogenous CNNM3 protein with minimal cross-reactivity to related proteins.
  2. Broad Applications:
    • Western Blot (WB): Detects CNNM3 protein in cell and tissue lysates.
    • Immunofluorescence (IF): Studies subcellular localization.
    • Immunohistochemistry (IHC): Visualizes CNNM3 expression in tissue samples.
  3. Validated Species:
    • Suitable for human, mouse, and rat samples.
  4. Reliable Performance:
    • High reproducibility across experimental conditions and platforms.

Applications in Research

  1. Magnesium Homeostasis:
    • Investigates CNNM3’s role in maintaining magnesium ion balance.
  2. Cancer Research:
    • Explores the role of CNNM3 in tumor growth, invasion, and metastasis.
  3. Metabolic Studies:
    • Analyzes CNNM3’s impact on cellular energy pathways and metabolism.
  4. Drug Development:
    • Assesses CNNM3 as a potential therapeutic target in oncology and metabolic disorders.

Protocols for CNNM3 Polyclonal Antibody Use

Western Blot (WB):

  1. Sample Preparation:
    • Lyse cells or tissues and quantify protein concentration.
  2. Electrophoresis:
    • Separate proteins on SDS-PAGE and transfer them to a membrane.
  3. Primary Antibody Incubation:
    • Dilute CNNM3 Polyclonal Antibody (1:1000–1:5000 recommended) and incubate overnight.
  4. Secondary Antibody:
    • Use HRP-conjugated secondary antibody and detect using a chemiluminescence system.

Immunohistochemistry (IHC):

  1. Sample Preparation:
    • Fix and embed tissue samples, followed by antigen retrieval.
  2. Primary Antibody Incubation:
    • Apply CNNM3 antibody diluted in a suitable buffer.
  3. Detection:
    • Use an enzyme or fluorophore-labeled secondary antibody and counterstain.

Benefits of the CNNM3 Polyclonal Antibody

  1. High Sensitivity:
    • Detects CNNM3 at low expression levels, enabling early-stage research.
  2. Versatility:
    • Compatible with multiple experimental techniques.
  3. Reproducibility:
    • Reliable results across various sample types and conditions.
  4. Cost-Effective:
    • Provides a high-performance alternative to monoclonal antibodies.

Challenges and Future Directions

Challenges:

  • Optimization: Experimental conditions may require fine-tuning.
  • Sample Variability: Cross-reactivity can occur in some complex sample types.

Future Innovations:

  1. Multiplex Antibodies:
    • Development of panels for studying CNNM3 alongside other transporters.
  2. Therapeutic Applications:
    • Utilize CNNM3 in designing targeted cancer therapies.
  3. Advanced Imaging:
    • Integration with super-resolution microscopy for detailed studies.

Conclusion

The CNNM3 Polyclonal Antibody is a vital tool for advancing research in ion transport, metabolism, and cancer biology. Its specificity and versatility make it indispensable for uncovering CNNM3’s functions and implications in health and disease.

For more information and technical support, visit: